Medpace Holdings, Inc.MEDPNASDAQ
Loading
MEDP Revenue Growth (YoY Quarterly)•+32.03%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+32.03%
+8.3pp
+15.14%
-1.4pp
+23.39%
-1.7pp
+22.25%
-4.1pp
+15.48%
+0.2pp
+26.46%
-0.6pp
+27.25%
-1.3pp
-8.58%
-2.1pp
-9.53%
-2.1pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.66% | +9.30% | +14.24% | +23.74% | +32.03% |
| Gross Profit Growth | +30.34% | +14.96% | +17.01% | +16.53% | +15.14% |
| EBITDA Growth | +37.72% | +8.46% | +4.65% | +25.12% | +23.39% |
| Operating Income Growth | +43.58% | +9.08% | +20.15% | +26.31% | +22.25% |
| Net Income Growth | +49.45% | +11.70% | +2.16% | +15.25% | +15.48% |
| EPS Growth | +48.24% | +13.55% | +10.88% | +27.01% | +26.46% |
| EPS Diluted Growth | +49.19% | +14.69% | +12.73% | +28.57% | +27.25% |
| Weighted Average Shares Growth | +0.74% | -1.48% | -4.84% | -6.49% | -8.58% |
| Weighted Average Shares Diluted Growth | +0.59% | -2.52% | -5.99% | -7.41% | -9.53% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +21.91% | -17.58% | +27.60% | +65.16% | +1.04% |
| Free Cash Flow Growth | +25.01% | -21.29% | +37.56% | +89.35% | +2.78% |
| Receivables Growth | -0.66% | +6.82% | +25.51% | +19.77% | +35.63% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +26.80% | +5.66% | -18.14% | -15.88% | -5.97% |
| Book Value per Share Growth | +46.62% | -10.28% | -76.28% | -64.38% | -39.18% |
| Debt Growth | -11.18% | -6.97% | +13.68% | +12.24% | +98.44% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +6.87% | +31.34% | +12.57% | -2.31% | -1.14% |
1 / 4